Today on DNA Day, we celebrate all the remarkable ways DNA enhances health, advances science, and impacts numerous industries. We also honor the pioneering work of our namesake, Rosalind Elsie Franklin, whose discovery of DNA's double helix structure has laid the foundation for our field. ?? Franklin was a true pioneer, and her invaluable contributions have not only inspired our work but have also fueled a myriad of groundbreaking advancements across the world. ?? ? #DNADay #DNA #Biotech #Biotechnology #RosalindFranklin
关于我们
Elsie’s technology relies on a three dimensional platform that allows for the synthesis, deconvolution, and delivery of homogeneous oligonucleotide therapeutics. Our hope to leverage an out of the box way of thinking as well as a multidisciplinary approach to bring safer and more efficacious therapeutics to the market to treat the most intractable human diseases.
- 网站
-
https://www.elsiebio.com
Elsie Biotechnologies的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- San Diego，California
- 类型
- 私人持股
地点
-
主要
获取路线
10355 Science Center Dr
US，California，San Diego，92121
Elsie Biotechnologies员工
-
Kevin Green
Experienced CBO, CFO, and COO. I bring transformative leadership to revitalize companies and teams to maximize value
-
Jouissance-Nicole Ysrael (Cayas)
Director, Accounting, Human Resources & Operations
-
Bibiana Rius
Senior Scientist I at Elsie Biotechnologies
-
Dillon Flood
Co-Founder and Scientific Director at Elsie Biotechnologies
动态
-
Join us at TIDES USA in Boston next month! Kyle Knouse will present "The Next-generation of Oligonucleotide Chemistry Using the P(V) Platform." We look forward to sharing our insights and hearing from other industry peers. #Biotechnology #TidesUSA #Tides #Oligonucleotide #Oligonucleotides
-
-
We’re excited to launch “Elsie Value Days,” a new initiative designed to foster personal and community growth in alignment with our core values. ? ? Dianne, Blythe, and Bibiana recently led a session at San Diego High School, sharing their STEM journey and guiding students through ELISA experiments. ?? A field trip to Elsie followed up this hands-on learning experience. Students explored our lab, gaining insight into a scientist’s daily life, and learning more about our science. ?? This initiative brought science to life for students and inspired pathways for future careers in biotechnology. Keep an eye out for future Elsie Value Days to come! #CoreValues #ElsieValueDays #Volunteering #SanDiego #SanDiegoHighSchool #STEM #CareersInSTEM #STEMEducation
-
-
-
-
-
+5
-
-
#TBT to when our Co-founder and Director of Chemistry, Kyle Knouse, facilitated a roundtable at the Oligonucleotide Therapeutics Roundtable Xchange in San Diego. It was an insightful discussion about medicinal chemistry within oligonucleotide therapeutic advancement. #hubXchange #lifesciences #biotech #oligonucleotide #biotechnology
-
-
Learn about our latest advancements in oligonucleotide therapeutics with Dillon Flood in LatchBio’s upcoming webinar on March 21st. ?? ??
Want to learn how Elsie Biotechnologies is advancing the future of oligonucleotide therapeutics? Join us on March 21st for our webinar with Elsie Biotechnologies, an industry leader in oligonucleotide therapeutics, who recently partnered with GSK to revolutionize the development of safer, more effective therapeutics, while pushing the boundaries of drug discovery. During this webinar, we’ll hear from Dillon Flood, Elsie’s Co-Founder and Scientific Director, to learn more about their platform, their recent partnership with GSK, and the future of oligonucleotide therapies. Register here to save your seat: https://lnkd.in/gUriiEav
-
-
? A big congratulations Blythe Dillingham, Ph.D., for her promotion to Director of Biology! We are so thankful for your contributions to Elsie and your leadership guiding our preclinical programs to success. #Biology #Biotech #Biotechnology #CareerDevelopment
-
Today one in ten Americans are living with a rare disease, while globally, the number exceeds 300 million individuals. ?? We show our stripes to support and raise awareness for all of those impacted by rare diseases and stay committed to treating undruggable diseases. ?? #RareDiseaseDay #ShowYourStripes
-
-
Join us tomorrow at the Oligonucleotide Therapeutics Roundtable Xchange in San Diego! Elsie co-founder and Director of Chemistry, Kyle Knouse, will lead a roundtable discussion, diving deep into how medicinal chemistry is advancing the efficacy of oligonucleotide therapeutics.?
How can medicinal chemistry be utilized to enhance the effectiveness of oligonucleotide therapeutics? Join?Kyle Knouse?and others in a roundtable discussion on the topic at our Oligonucleotide Therapeutics Roundtable Xchange happening in San Diego February 28th, 2024. View agendas for upcoming xchanges, find out more and register to join at?https://lnkd.in/eXpNsFQd Registration is only open to Senior Scientists and above actively working in the pharmaceutical/biotech industry. Each roundtable is limited to 8 participants.?#hubXchangeNotAConference #lifesciences?#pharma?#pharmaceutical?#pharmacology?#biotech?#biotechnology?#biotechnews?#oligonucleotides?#therapeutics?#development?#manufacturing?#drugdevelopment?#drugdiscovery?#drugdelivery?#drugspharmaceuticals?#drugproduct?#drugmanufacturing?#drugsubstance
-
-
LatchBio has supported advancing the science behind our platform. Join Dillon Flood as he delves into the details of these advancements during their webinar on March 21.
Oligonucleotide therapies are a rapidly advancing field of biotechnology that promise to cure previously undruggable diseases with small fragments of RNA. Leveraging advances in accessible computation to power ultra high-throughput experimentation,?Elsie Biotechnologies?is building a new platform for the design, testing, and validation of oligonucleotide therapeutics at an unprecedented scale. Learn about the mechanics of their platform and how their partnership with LatchBio has accelerated their science. Read out the full case study here:?https://lnkd.in/g8eFuSti Have questions about Elsie or their science? Register for our webinar to ask Elsie's co-founder, Dillon Flood, directly.?https://lnkd.in/gewrzxTG
-
-
We are excited to announce that, following a successful outcome of the research collaboration, GSK has exercised its option to a non-exclusive license to Elsie’s discovery platform in its own oligonucleotide drug discovery research. https://lnkd.in/e2He5CNZ ? #BiotechNews #Licensing #Biotechnology #PharmaNews #DrugDiscovery #oligonucleotide